Principal Healthcare Innovators ETF (BTEC)
| Assets | $48.16M |
| Expense Ratio | 0.42% |
| PE Ratio | n/a |
| Shares Out | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +9.07% |
| Volume | 3,644 |
| Open | 36.43 |
| Previous Close | 37.09 |
| Day's Range | 36.33 - 36.50 |
| 52-Week Low | 25.66 |
| 52-Week High | 38.00 |
| Beta | n/a |
| Holdings | 227 |
| Inception Date | Aug 19, 2016 |
About BTEC
Fund Home PageThe Principal Healthcare Innovators ETF (BTEC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to hold equities of small- and mid-cap healthcare firms in the US. The fund uses a proprietary, quantitative model to construct the portfolio. BTEC was launched on Aug 19, 2016 and is issued by Principal.
Top 10 Holdings
22.83% of assets| Name | Symbol | Weight |
|---|---|---|
| Exact Sciences Corporation | EXAS | 3.18% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 3.09% |
| Karuna Therapeutics, Inc. | KRTX | 2.81% |
| Bio-Rad Laboratories, Inc. | BIO | 2.20% |
| Illumina, Inc. | ILMN | 2.05% |
| Sarepta Therapeutics, Inc. | SRPT | 2.00% |
| ImmunoGen, Inc. | IMGN | 1.96% |
| Cytokinetics, Incorporated | CYTK | 1.95% |
| BridgeBio Pharma, Inc. | BBIO | 1.84% |
| Elanco Animal Health Incorporated | ELAN | 1.76% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 29, 2021 | $0.45322 | Jan 3, 2022 |
| Dec 17, 2020 | $0.21542 | Dec 22, 2020 |
| Dec 15, 2017 | $0.04155 | Dec 20, 2017 |
News
Build Off Growth in Healthcare Innovation With BTEC
If the ongoing pandemic has taught anything, it's the need for healthcare innovation. That's exactly what the Principal Healthcare Innovators ETF (BTEC) is all about.
Goldman Sachs Likes These Health Tech Stocks
Broadly speaking, the healthcare sector is generally viewed as defensive, but there growing pockets of disruption and innovation in the space, including health technology equities. For investors looki...
An ETF to Home In on Innovative Health Care Growth
An exchange traded fund that tracks healthcare and technology themes can help diversify and enhance investment portfolios. In the recent webcast, Investing for tomorrow, today: Exploring the future of...
Investing for Tomorrow, Today: Exploring the Future of Health Care
In the upcoming webcast, Investing for tomorrow, today: Exploring the future of health care, Steve Jones, Client Portfolio Manager, Principal Global Systematic Solutions; Jeffrey Schwarte, Portfolio M...
Health Tech x Remote Work: Principal's BTEC ETF
The coronavirus pandemic altered the healthcare landscape and how and where people work. The Principal Healthcare Innovators Index ETF (BTEC) is an exchange traded fund at the epicenter of those theme...
AI Can Drive the Next Generation of Healthcare Innovation
When it comes to innovation, healthcare is a sector-level leader, especially when the Principal Healthcare Innovators Index ETF (BTEC) taps into that trend. BTEC seeks to provide investment results th...
Biotech ETFs Pop Amid Pending J&J Vaccine Approval
Biotech ETFs are climbing Wednesday as the Food and Drug Administration's staff endorsed Johnson & Johnson's coronavirus vaccine for emergency use, a key step in offering a third vaccination to the U....
Bank on BTEC in the Ever-Elusive Search for Healthcare Innovation
The Principal Healthcare Innovators Index ETF (BTEC) became quite the story among healthcare exchange traded funds last year. BTEC seeks to provide investment results that closely correspond, before e...
Moderna Helps Biotech ETFs Mitigate Massive Losses as Stocks Tumble
While much of the stock market and associated index ETFs are bathed in red to start the new year, Moderna is rallying, as the biotech company is boosting its vaccine output to help the spiking infecti...
Principal on Trends in Portfolio Construction Amid 2020 Volatility
ETF Trends CEO Tom Lydon spoke with Ed Nini, Global Head of Product Strategy for Principal Global Investors, about the tumultuous year that has been 2020 and what kinds of strategies have been put int...
The BTEC ETF: Access to Consistent Healthcare Innovation
Bolstered by positioning that includes exposure to companies fighting the coronavirus pandemic, the Principal Healthcare Innovators Index ETF (BTEC) is a pleasant surprise among healthcare exchange tr...
Principal's BTEC ETF Luring Investors Seeking Telemedicine Exposure
The Principal Healthcare Innovators Index ETF (BTEC) is often viewed as an exchange traded fund with access to biotechnology stocks and companies working on coronavirus vaccines. That's true, but the ...
ETF Opportunities Abound in an Increasingly Monolithic Healthcare Industry
With progress being made on the coronavirus vaccine front, the Principal Healthcare Innovators Index ETF (BTEC) is an example of a healthcare exchange traded fund getting into its groove. Fortunately,...
Best Biotech ETFs for Q1 2021
The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.
The Intensifying Vaccine Race Spells Success for BTEC
The race to bringing a coronavirus vaccine to market is heating up. That spells opportunity for the Principal Healthcare Innovators Index ETF (BTEC).
Is Principal's BTEC the Healthcare ETF to Hold Come Election Day?
The Principal Healthcare Innovators Index ETF (BTEC) is among the healthcare exchange traded funds that have encountered some rough sledding of late due to pre-Election Day jitters. However market obs...
The Principal Healthcare ETF Thriving under Vaccine Progress
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is an example of an exchange traded fund that's been sensitive to coronavirus vaccine headlines. While there's a lot to like about the Prin...
3 Health Care ETFs Where Components Are Enduring Downgrades
After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.
3 ETFs To Play Gilead's $21B Immunomedics Takeover
Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring Immunomedics (NASDAQ: IMMU) for $21 billion.
Innovation Sets This Healthcare ETF Apart
Among healthcare ETFs, the Principal Healthcare Innovators Index ETF (BTEC) is one of the names taking the category by storm this year. BTEC seeks to provide investment results that closely correspond...
A Targeted Biotech ETF to Access Next-Gen Healthcare Opportunities
As we take a closer look at the opportunities in the biotechnology industry, investors can focus on healthcare developments posed to support rapid growth through a targeted exchange traded fund invest...
Coronavirus Vaccine is Coming, Providing Catalysts for this ETF
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is already on a scintillating pace this year and that upside could be extended as a wave of coronavirus vaccines hits the wires over the ne...
A Healthcare ETF Offering Some Immunity During Election Year
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is among the cadre of healthcare ETFs that are soaring this year owing to the COVID-19 pandemic, but with Election Day drawing closer, inve...
Possibilities Remain Plentiful for This Innovative ETF
With significant tailwinds by way of the coronavirus pandemic, the Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is a rising star among healthcare ETFs. Fortunately, the long-term outlook f...